Trial intelligence / Profile preview

Zinc Supplementation in Beta-Thalassemia Major with Diabetes

NCT03851055Phase 3Completed

Sponsor
Ain Shams University
Start
Aug 2017
Primary completion
Jul 2018
Countries
1
01

Overview

Phase 3, randomised, double-blind trial (2 arms), sponsored by Ain Shams University. Primary endpoint: Fasting blood glucose at 12 weeks. Started Aug 2017; status: completed.

Beyond the preview

Go deeper on NCT03851055.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03851055.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call